Developing new methods for creating important chemical structures using innovative chemistry.
Selective Chemical Synthesis and Catalysis Enabled by Single-Electron Oxidation of Aromatic N-oxides
This study is looking at new ways to create and improve medicines using special chemistry techniques, which could help develop better treatments for various diseases that patients may face.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11066533 on NIH RePORTER |
What this research studies
This research focuses on creating new synthetic strategies and catalysts by utilizing single-electron transfer chemistry of aromatic N-oxides, which are versatile and readily available compounds. The goal is to enhance our understanding of this chemistry to enable the development of new therapeutic agents and improve the synthesis of existing ones. By exploring this unconventional approach, the research aims to facilitate the design and manufacture of medicines that can effectively manage and treat various diseases. Patients may benefit from advancements in drug development resulting from this innovative chemical synthesis.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that require innovative therapeutic agents or improved drug formulations.
Not a fit: Patients with conditions that are not addressed by new chemical synthesis or those who do not require novel therapeutic agents may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient development of new medications for various diseases.
How similar studies have performed: Other research has shown promise in utilizing unconventional chemistry for drug development, indicating potential success for this innovative approach.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Deng, Yongming — Indiana University Indianapolis
- Study coordinator: Deng, Yongming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.